Decent trading update found here..http://www.companyannouncements.net/cgi-bin/articles/200601090700205996W.htmlMarketing of Vetoryl capsules in Europe to begin before the end of June, and a regulatory aplication package intended to be submitted in late 2007. Group revenue growth at 11% amidst increased product development expenditure.In summary, expansion remains as planned and the cashflow generation and evaluation of DPH are supportive of further increases in the SP as revenue flows (hopefully) start to 'kick in' in future years, IMHO.
© Copyright 1998-2013, The Motley Fool Limited. All rights reserved. This material is for personal use only.The Motley Fool, Fool, and the "Fool" logo are registered trademarks of The Motley Fool, Inc.Place of Reg: England & Wales. Company Reg No: 3736872. VAT Reg No: 945 6990 68. Registered Office: 5th Floor, 60 Charlotte Street London W1T 2NU.
Page load time and server: